维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Piccinino"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Trends in contraceptive use in the united states: 1982-1995 显示文摘	Piccinino LJ Mosher WD	1998	Fam Plann Perspect1998，30，1：	1
	2	Applying nationalsurvey results for strategic planning and programimprovement :the National Diabetes Education Program显示文摘	Griffey S Piccinino L Gallivan J	2015	Eval Program plann2015，48，：	1
	3	Complications following percutaneous liver biopsy:A multicentre retrospective study on 68276 biopsies显示文摘	Piccinino F SagnellI E Pasquale G	1986	J Hepatol1986，2，2：	1
	4	Abnormal steroid sulfate in plasma of women with intrahepatic cholestasis of pregnancy 显示文摘	Giusti G Piccinino F Ricciardi Ⅰ	1979	Acta Hepatogastroenterol1979，26，3：	1
	5	Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C:an Italian multicentre study on dose and duration of IFN alpha treatment显示文摘	Piccinino F Felaco FM Sagnelli E		0，，05：	1
	6	Aortic valve replacement in patients over 70:a Doppler echocardiographic study显示文摘	Sarasso G Airoldi L Piccinino C	1998	Cardiologia1998，43，10：	1
	7	Influence of Chronic Coinfection with Hepatitis B and C Virus on Liver Histology显示文摘	E. Sagnelli G. Pasquale N. Coppola F. Scarano C. Marrocco C. Scolastico T. Santantonio A. Gentile F. Piccinino	2004	Infection2004，，3：	1
	8	Muhicentre double - blind placebo - controlled study of intravenous and oral S - adenosy - L - methionioe(SAMe) in cholestatic patients with liver disease 显示文摘	Manzillo G piccinino F Surrenti C	1992	Drug Invest1992，4，4：	1
	9	Virologic and Clinical Expressions of Reciprocal Inhibitory Effect of Hepatitis B, C, and Delta Viruses in Patients With Chronic Hepatitis显示文摘	Evangelista Sagnelli Nicola Coppola Carlo Scolastico Pietro Filippini Teresa Santantonio Tommaso Stroffolini Felice Piccinino	2000	Hepatology2000，，5：	1
	10	Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation显示文摘	Eraldo Occhetta Miriam Bortnik Andrea Magnani Gabriella Francalacci Cristina Piccinino Laura Plebani Paolo Marino	2006	Journal of the American College of Cardiology2006，，10：	1
	11	Multicentre double-blind placebo-controlled strdy of intravenous and oral S-adenosyl-L-methionine(SAME)in cholestatic patients with liver disease显示文摘	Manzillo G Piccinino F Surrenti C	1992	Drug Invest1992，，：	1
	12	Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosyl-L-methionine (SAMe)in cholestatic patients with liver disease显示文摘	Manzillo G Piccinino F Surrenti C	1992	Drug Invest1992，4，4：	1
	13	Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation显示文摘	Eraldo Occhetta Miriam Bortnik Andrea Magnani Gabriella Francalacci Cristina Piccinino Laura Plebani Paolo Marino	2006	Journal of the American College of Cardiology2006，，10：	1
	14	Antiviral treatment of HCV- related cir-rhosis显示文摘	Piccinino F Coppola N	2007	Dig Liver Dis2007，39，1：	1
	15	Effect ofimmuno-suppressive therapy on HBsAg positive chronic active hepatitis in relation to presence and absence of HBsAg and anti-Hbe 显示文摘	Sagnelli E Piccinino F Marzollo G	1983	Hepatology1983，3，5：	1
	16	Applying national survey re- sults for strategic planning and program improvement:The National Diabetes Education Program显示文摘	Griffey S Piccinino L Gallivan J	2015	Evaluation and Program Planning2015，，48：	1
	17	The effectiveness of four clinical irrigation methods on the removal of root canal debris 显示文摘	Abou-Rass M Piccinino MV	1982	Oral Surg Oral Med Oral Patbol1982，54，3：	1
	18	Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B显示文摘AIM:To evaluate safety and effect on hepatitis B virus(HBV)suppression of a long-term treatment with lamivudine(LAM)at standard(100 mg/d)or double(200 mg/d)dose in chronic hepatitis B.METHODS:This was a case study with matched controls(1:3)in patients with chronic hepatitis B with anti-HBe antibodies.RESULTS:Twelve patients received LAM 200 mg/d and 35 LAM 100 mg/d,for a median of 28 mo.A primary response(PR;i.e.negative HBV-DNA with Amplicor assay)was achieved in 100% of LAM-200 patients and 83% of LAM-100 patients.A virological breakthrough occurred in 16.7 and 24.7%,respectively,of the PR-patients,with the appearance of typical LAM resistance mutations in all but one patient.Viremia blips(i.e.transient HBV-DNA below 80 IU/mL in patients who tested negative at Amplicor assay)were detected using a real time polymerase chain reaction(PCR)and occurred in seven out of nine patients with subsequent BT and in four out of 32 patients with end-of-study response(77.7% vs 12.5%;P = 0.001)at chi-square test).At the end of the study,51.4% of LAM-100 patients and 83.3% of LAM-200 patients had remained stably HBV-DNA negative.Double-dose LAM was well tolerated.CONCLUSION:Long-term treatment of anti-HBe positive chronic hepatitis B with double dose lamivudine causes a more profound and stable viral suppression ascompared to conventional treatment.	Gianfranca Stornaiuolo Maria Stanzione Giuseppina Brancaccio Gianluca Cuomo Vincenza Precone Sebastiano Di Biase Francesca M Felaco Felice Piccinino Giovanni B Gaeta	2007	World Journal of Gastroenterology2007，13，42：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费